UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

PENGARUH PEMBERIAN INSULIN TERHADAP EKSPRESI HYPOXIA INDUCIBLE FACTOR-1 , VASCULARENDOTHELIAL GROWTH FACTOR- β,DAN CASPASE-3 PADA MIOKARD TIKUS YANG MENGALAMI HIPERGLIKEMIA AKUT DAN HIPOKSIA

dc.contributor.authorToni, Prasetia
dc.contributor.otherNur Indrawaty, Lipoeto
dc.contributor.otherYanwirasti, Yanwirasti
dc.contributor.otherMasruk, Masrul
dc.date.accessioned2026-09-24T23:58:06Z
dc.date.issued2023-03-08
dc.descriptionProf. dr. Nur Indrawaty Lipoeto, MSc, PhD, SpGK
dc.description.abstractABSTRAK PENGARUH PEMBERIAN INSULIN TERHADAP HIF-1, VEGF- β, DAN CASPASE-3 PADA MIOKARD TIKUS PERCOBAAN YANG MENGALAMI HIPERGLIKEMIA DENGAN HIPOKSIA Toni Prasetia Penelitian ini bertujuan untuk menganalisis pengaruh pemberian insulin terhadap HIF-1, VEGF-β, dan Caspase-3 pada miokard tikus percobaan yang mengalami hiperglikemia dengan hipoksia. Dengan hasil penelitian diharapkan dapat menambah pengetahuan mengenai peranan insulin terhadap apoptosis miokard yang terjadi pada keadaan hiperglikemia dengan hipoksia sehingga dapat menurunkan angka morbiditas maupun mortalitas pada penderita diabetes akibat penyakit koroner. Metode penelitian ini adalah eksperimental murni, semua variabel dikendalikan dengan post test only control group design. Digunakan 30 ekor tikus jantan galur wistar berusia 3 bulan dengan 200–250 gr yang dibagi menjadi 2 kelompok dengan teknik simple random sampling. Sebelum diberikan perlakuan, dilakukan pengecekan glukosa darah pada kedua kelompok. Selanjutnya, kedua kelompok dikondisikan menjadi hiperglikemia dan hipoksia selama beberapa waktu. Kemudian, pada kelompok pertama diberikan insulin sedangkan pada kelompok kedua tidak diberikan insulin. Setelah itu diperiksa ekspresi HIF-1, VEGF-β, dan Caspase-3 dengan menggunakan imunohistokimia. Analisis data menggunakan uji t dengan data sampel dianalisis terlebih dahulu menggunakan uji normalitas data (uji Shapiro Wilk). Hasil : rerata glukosa darah pada kelompok pertama adalah 174 ± 8,80 mg/dl sedangkan kelompok kedua adalah 173,67 ± 10,10 mg/dl. Rerata nilai HIF-1 pada kelompok pertama adalah 77,33 ± 12,79% sedangkan kelompok kedua 63,33 ± 24,97%. Rerata nilai VEGF-β pada kelompok pertama adalah 13,67 ± 8,76% dan kelompok kedua senilai 37,33 ± 15,80%. Rerata nilai Caspase-3 pada kelompok pertama adalah 58 ± 23,05% sedangkan kelompok kedua adalah 41,33 ± 24,75%. Pemberian insulin meningkatkan level ke-3 nya tetapi dengan t-tes hanya VEGF-β yang bermakna. Kesimpulan penelitian ini, insulin hanya berpengaruh terhadap ekspresi VEGF-β, tidak pada HIF-1 dan Caspase-3 Kata Kunci: Hiperglikemia, Hipoksia, HIF-1, VEGF-β, Caspase-3, Insulin Abstract EFFECT OF GIVING INSULIN ON CASPASE 3, HIF-1, VEGF IN MIOCARD EXPERIMENT RATS WHICH HAVE EXPERIENCED ISKEMIA AND HYPERGLYCEMIA Toni Prasetia Background: Hypoxia in myocytes stimulates cellular protection mechanisms so that cells can survive and prevent apoptosis, but the state of hyperglycemia causes this protective mechanism to be disrupted. Anabolic effects of insulin have been agreed. Morbidity and mortality can be reduced by administering insulin. The levels of HIF-1, VEGF and Caspase-3 can be more stable, last longer and increase the protective effect of cardiac myocytes and reduce myocyte apoptosis. Methods: This was an experimental control group design of 30 Wistar rats in aloxan-induced hyperglycemia 2 weeks before and acute hypoxia for 2 days and had fulfilled the inclusion criteria divided into insulin treatment and control groups. NPH insulin is given 1 morning and 6 hours afterwards. Changes in HIF- 1, VEGF and Caspase-3 levels were examined on the second day of hypoxia Results: Statistical analysis showed a higher average number of HIF-1 in the treatment group than in the control group (55.63 ± 2.17%) with insulin administration. Similar results can also be seen in VEGF-β in the treatment group (16.69 ± 0.94%) higher than in the control group (28.06 ± 1.26%). Meanwhile, the amount of Caspase-3 in the treatment group showed higher results (58.69 ± 1.18%) when compared to the control group (27.50 ± 1.24%). The administration of insulin shows an increase in the third level. Although the statistical analysis test with t-test only showed a statistically significant increase only in the treatment group and VEGF β control (p <0.05) Conclusion: From the calculation of the analysis showed that insulin administration in diabetic hypoxic rats had a significant effect on the significant increase in VEGF β levels but not in the HIF-1 and Caspase-3 groups
dc.identifier.urihttps://ailib.my.id/handle/123456789/74557
dc.language.isoid
dc.publisherFakultas Kedokteran
dc.subjectHiperglikemia
dc.subjectHipoksia
dc.subjectHIF-1
dc.subjectVEGF-β
dc.subjectCaspase-3
dc.subjectInsulin
dc.subject.classificationR Medicine (General)
dc.titlePENGARUH PEMBERIAN INSULIN TERHADAP EKSPRESI HYPOXIA INDUCIBLE FACTOR-1 , VASCULARENDOTHELIAL GROWTH FACTOR- β,DAN CASPASE-3 PADA MIOKARD TIKUS YANG MENGALAMI HIPERGLIKEMIA AKUT DAN HIPOKSIA
dc.typeThesis
dcterms.dateSubmitted2024-02-26
dcterms.referencesDAFTAR PUSTAKA Aikawa, R., Nawano, M., Gu, Y., Katagiri, H., Asano, T., Zhu, W ., 2000, 'Insulin Prevents Cardiomyocytes From Oxidative Stress–Induced Apoptosis Through Activation of PI3 Kinase/Akt Circulation', Circulation, vol. 02, no. 23, hh. 2873-9. Amanda ,Pharrish, Christoper D. Sally K.,2013,Cellular Mechanisms Controlling Caspase Activation and Function. Coldspring habBiol.5(6)a00.8672 Ambrose, L.J., Abd-Jamil, A.H., Gomes, R.S., Carter, E.E., Carr, C.A., Clarke, K & Heather, L.C., 2014, 'Investigating Mitochondrial Metabolism in Contracting HL-1 Cardiomyocytes Following Hypoxia and Pharmacological HIF Sctivation Identifies HIF-dependent and independent Mechanisms of Regulation', Journal of Cardiovascular Pharmacology and Therapeutics, vol. 19, no. 6, hh. 574–85. American Diabetes Association, 2007. 'Clinical Practice Recommendations'. Diabetes Care, vol. 30 no. suppl 1, hh. S1-S103. Andersen, S.K., Gjedsted, J., Christiansen, C & Tønnesen, E., 2004, 'The roles of insulin and hyperglycemia in sepsis pathogenesis', Journal of Leukocyte Biology, vol. 75, no. 3, hh. 413-21. Bandeira. 2013. Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus. Int Jour Med.14(2)3265-84. Biddlestone J, Bandara D, Rocha S.,2015. The Role of HypoxiaIn Inflammatory disease .DOI: 10.3892/ijmm.2015.2079 Bing R, Hu, Cun liu, Yibiang Quyang, 2000, Involvement of caspase-3 in cell death after hypoxia-ischemia declines during barain maturation, journal of cerebral bloodflow and metabolism, vol 20:1294-3000. Bir, S.C., Esaki, J., Marui, A., Yamahara, K., Tsubota, H., Ikeda dkk., 2009, Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse', Journal of Vascular Surgery, vol. 50, no. 4, hh. 870–9. Bohren, E., Bottino, D.A & Tavares, J.C., 2003, 'The aldo-ketoreductase superfamily cDNAs and reduced aminoacids sequences in human aldehyde and aldose reductase', The Journal of Biological Chemistry, vol. 264, no. 16, hh. 9547-51. Bohuslavova., R, Kolar, F., Sedmera, D., Skvorova, L., Papousek, F., Neckar, J et al., 2012, 'The role of hypoxia inducible factor 1α in diabetic cardiomyopathy', Czech Republic. Bohuslavova, R., Kolar, F., Sedmera, D., Skvorova, L., Papousek, F., Neckar, J et al., 2014, 'Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice', BMC Endocrine Disorders, vol. 14, hh. 11. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA (2001). Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol.; 79: 207–214. Brownlee, M., 2001, 'Biochemistry and molecular cell biology of diabetic complication', Nature, vol. 414, hh. 813-20. Brownlee, M., 2005, 'The pathology of diabetic complication: a unifying mechanism', Diabetes, vol. 54, no. 6, hh. 1615-25. Buerke, M., Murohara, T., Skurk, C., Nuss, C., Tomaselli, K & Lefer, A.M., 1995, 'Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion', Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, hh. 8031– 5. Cai, L., Chen, S., Evans, T., Deng, D.X., Mukherjee, K & Chakrabarti, S., 2000, 'Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism', Urological research, vol. 28, no. 5, hh. 342 –7. Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y., Kang, Y.J., 2002, 'Hyperglycemia-Induced Apoptosis in Mouse Myocardium Mitochondrial Cytochrome c–Mediated Caspase-3 Activation Pathway', Diabetes, vol. 51, no. 6, hh. 1938–48. Cameron, N.E & Cotter, M.A., 2008, 'Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway', Current Drug Targets, vol. 9, no.1, hh. 60–7. Cao, R., Bråkenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E et al., 2003, 'Angiogenic synergism, vascular stability improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2', Nature Medicine, vol. 9, no. 5, hh. 604–13. Capes, S.E., Hunt, D., Malmberg, K & Gerstein, H.C., 2000, 'Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview', Lancet, vol. 355, no. 9206, hh. 773–8. Catrina, S.B., Okamoto, K., Pereira, T., Brismar, K & Poellinger, L., 2004, 'Hyperglycemia regulates hypoxia-inducible factor-1α protein stability and function'. Diabetes, vol. 53, no. 12, hh. 3226–32. Cave A.C., Ingwall, J.S., Friedrich, J., Liao, R., Saupe, K.W., Apstein, C.S. et al., 2000, 'ATP synthesis during low flow ischemic infuences of increased glycolitic substrate', Circulation, vol. 101, hh. 2090-6. Changbo D, Juan LFengjie S,jigging X, 2019. Effect of hypoxia ischemia on caspase-3 expression and neural apoptosis in the brain of neonatal mice. Doi org, vol 1;3892. Ming C.M, Qazi M, Ashraf, Hahan Ara, Om P, Mishra,, 2007, mecahanisme of caspase-3 activation during hypoxia in the cerebral cortex of newborn piglets, neuro science letters, vol421,issue 1,P67-71. Clement, S., Braithwaite, S.S., Magee, M.F., Ahmann, A., Smith, E.P & Schafer, R.G., 2004, Management of diabetes and Hyperglycemia in hospital. Diabetes care, vol. 27, no. 2, hh. 553-91. Das U.N., 2000. 'Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction'. Molecular and Cellular Biochemistry, vol. 215, no. 1-2, hh. 145–52. Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., Greenber, M.E., 1997, 'Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery'. Cell, vol. 91, no. 2, hh. 231–41. Deedwania, P., Kosiborod, M., Barrett, E., Ceriello, A., Isley, W., Mazzone, T et al., 2008, 'Hyperglycemia and Acute Coronary Syndrome A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism', Ciculation, vol. 117, no. 12, hh. 1610-9. Departemen Kesehatan RI, 2012, Rencana Pembangunan Kesehatan Menuju Indonesia Sehat 2020, Jakarta. Devereux, R.B., Roman, M.J., Paranicas, M., O’Grady, M.J., Lee, E.T., Welty, T.K., et al 2000, 'Impact of diabetes on cardiac structure and function: the strong heart study'. Circulation, vol. 101, no. 19, hh. 2271-7. Du, X.L., Sui, G.Z., Stockklauser-Farber, K., Weiss, J., Zink S., Schwippert, B et al,. 1998, 'Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species', Diabetologia, vol. 41, no.3, hh. 249-56. Du, X.L et al., 2000, 'Hyperglicemia induced mitochondrial superoxide overproduction activator inhibitor-1 expression by increasing spl gycosylation', Proceedings of the National Academy of Sciences of the United States of America', vol. 97, no. 22, hh. 12222-6. Ebrahimian, T.G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L. et al., 2006, 'NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes', American Journal of Pathology, vol. 169, no.2, hh. 719–28. Elias, I., Franckhauser, S., Ferré, T., Vilà, L., Tafuro, S & Muñoz, S., 2012, 'Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance', Diabetes, vol. 61 no. 7, hh. 1801-13. Fan, X., Heijnen, C.J., van der Kooij, M.A., Groenendaal, F & van Bel, F., 2009, 'The role and regulation of alpha hypoxia-induced factors in the brain and brain of neonatal hypoxia-ischemic'. Brain Research Reviews, vol. 62, no. 1, hh. 99-108. Ferrara, N & Davis-Smyth, T., 1997, ' The biology of vascular endothelial growth factor', Endocrine Review, vol. 18, hh. 4-25. Foo, K., Cooper, J., Deaner, A., Knight, C., Suliman, A., Ranjadayalan, K et al,. 2003, 'A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes'. Heart, vol. 89, issue. 5, hh. 512–6. Ford, E.S., Giles, W.H & Dietz, W.H., 2002, 'Prevalence of metabolic syndrome among US Adult', Journal of the American Medical Association, vol. 287 no. 3, hh. 356-9. Forlani, S., Tomai, F., De Paulis, R., Turani, F., Colella, D.F., Nardi, P dkk., 2004, 'Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery', Journal of Cardiovascular Surgery, vol. 45, no. 2, hh. 117–22. Francis, G.S., 2001, 'Diabetic cardiomyopathy: fact or fiction?', Heart, vol. 85, no.3, hh. 247–8. Franke, T.F., Yang, S.I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K et al., 1995, 'The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase'. Cell, vol. 81, no. 5, hh. 727-36. Frank, S et al., 1995, 'Regulation of vascular endothelial growth factor expression in cultured keratocytes: implication for normal and impaired wound healing', Jounal of Biological Chemistry, vol. 270, hh. 12607-13. Freedman, S & Isner, J. M, 2002, 'Therapeutic angiogenesis for coronary artery disease', Annals of Internal Medicine, vol. 136, hh. 54-71. Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Len, A., Maseri, A dkk., 2000, 'Myocardial cell death in human diabetes', Circulation Research, vol. 7 no. 12, hh. 1123-32. Fukuda, R., Zhang, H., Kim, J.W., Shimoda, L., Dang, C.V & Semenza, G.L., 2007. 'HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells', Cell, vol. 129, no. 1, hh. 111-22. Gacka, M., Dobosz, T., Szymaniec, S., Bednarska-Chabowska, D., Adamiec, R & Sadakierska-Chudy, A,. 2010, 'Proinflammatory and atherogenic activity of monocytes in type 2 diabetes', Journal of Diabetes and its Complications, vol. 24, no. 1, hh. 1-8. Geissner C.A et al., 2007, 'Mechanism by which diabetes increases cardiovascular disease', Drug Discovery Today: Disease Mechanisms' vol. 4, no. 3, hh. 131-40. Gerber, H.P., Condorelli, F., Park, J & Ferrara, N., 1997, 'Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1 but not Flk-1/KDR, is up-regulated by hipoxia', Journal of Biological Chemistry, vol. 272, hh. 23659-67. Gerrit, D., 2001, 'Dispersyn and Marcel Borgers. Apoptosis in the Heart: About Programmed Cell Death and Survival', The International Union of Physiological Sciences, vol. 16, hh. 41-7. Goldin et al., 2006, 'Advanced glycation end products: sparking the development of diabetic vascular injury', Circulation, vol. 114, no. 6, hh 597-605. Gonzalez, Y., Herrera, M.T., Soldevila, G., Garcia-Garcia, L., Fabián, G., Pérez-Armendariz, E.M. et al., 2012, 'High glucose concentrations induce TNF-a production through the down-regulation of CD33 in primary human monocytes', BMC Immunology, vol. 13, hh. 19. Greijer A.E., Vande Wall., (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis, J Clin Pathol. 57(10) :1009-1014 Gupta, K & Zhang, J., 2005, 'Angiogenesis: a curse or cure', Postgraduate Medical Journal, vol. 81, hh. 236-42. Hafstad, A.D., Khalid, A.M., How, O.J., Larsen, T.S & Aasum, E., 2007, 'Glucose and insulin improve cardiac efficiency and post-ischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice', American Journal of Physiology-Endocrinology and Metabolism, vol. 292, no. 5, hh.E1288-94. Harmey, J. H & Bouvhier-Hayes, D, 2002, 'Vascular endothelial growth factor (VEGF), a survival factor for tumor cells: implication for anti-angiogenic therapy', Bioessay, vol. 24, hh. 280-3. Heather L.C., Cole, M.A., Tan, J.J., Ambrose, L.J., Pope, S., Abd-Jamil, A.H. et al., 2012. 'Metabolic adaptation to chronic hypoxia in cardiac mitochondria', Basic Research in Cardiology, vol. 107, no. 3, hh. 268. Homoud, M.K., 2008, 'Coronary Artery Disease', Tufts-New England Medical Center Spring, hh. 1-2, diakses dari https://www.oerafrica.org/ pada Sabtu, 21 Juli 2018 pukul 13.18 wib. Ilka Vaukonen, Leo Niskanen, Esko Vaninen, Sakari Kainlainen, Maati Uusitupa, 1997. Defects in Insulin Secretion and Insulin Action in Non–insulin-dependent Diabetes Mellitus Are Inherited Metabolic Studies on Offspring of Diabetic. J Clin Invest ,vol 101.1.86-96. Iliodromitis, E.K., Lazou, A & Kremastinos, D.T., 2007, 'Ischemic preconditioning: Protection against myocardial necrosis and apoptosis', Vascular Health and Risk Management, vol. 3, no. 5, hh. 629–37. Inoue S, Browne G, Melino G, Cohen GM 2009. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 16: 1053–1061 Inzuchi, S.E., 2012, 'Management of hyperglycemia in type 2 Diabetes, A Patient Centre Approach: Position Statement of the Ameican Diabetes Association (ADA) and the Europe Association for study of Diabetes (EASD)'. Diabetes Care, vol. 35, no. 6, hh. 1364-79. Irwan, B., 2007, 'Pencegahan Primer Penyakit Jantung Koroner Guna Menurunkan Angka Kesakitan dan Kematian Akibat Serangan Jantung', Pengukuhan Profesor, Universitas Gadjah Mada, Yogyakarta. Ishihara, M., Inoue, I., Kawagoe, T., Shimatani, Y., Kurisu, S., Nishioka, K et al., 2003, 'Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anteriorwall acutemyocardial infarction', American Heart Journal, vol. 146, no. 4, hh. 674–8. Jagasia, D., Whiting, J.M., Concato, J., Pfau, S & McNulty, P.H., 2001, 'Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease'. Circulation, vol.103, no. 13, hh. 1734–9. Jesmin, S., Zaedi, S., Shimojo, N., Iemitsu, M., Masuzawa, K., Yamaguchi, N dkk., 2007. 'Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts', American Journal of Physiology-Endocrinology and Metabolism, vol. 292 no. 4, hh. E1030-40. Jung, Y., Isaacs, J.S., Lee, S., Trepel, J., Liu, Z.G & Neckers, L., 2003, Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation', Biochemical Journal, vol. 370, no. Pt 3, hh. 1011-7. Kersten, J.R., Schmeling, T.J., Orth, K.G., Pagel, P.S & Warltier, D.C., 1998, 'Acute hyperglycemia abolishes ischemic preconditioning in vivo', Am J Physiol, vol. 275, no. 2, hh. 721–5. Kim, B.S., Chen, J., Weinstein, T., Noiri, E & Goligorsky, M.S., 2002, 'VEGF Expression in Hypoxia and Hyperglycemia: Reciprocal Effect on Branching Angiogenesis in Epithelial-Endothelial Co-Cultures', Journals of the American Society of Nephrology, vol. 3, no. 8, hh. 2027-36. Kim, J.W., Tchernyshyov, I., Semenza, G.L & Dang, C.V., 2006, 'HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia', Cell Metabolism, vol. 3, no. 3, hh. 177-85. Klein, O.L., Krishnan, .JA., Glick, S & Smith, L.J., 2010, 'Systematic review of the association between lung function and Type 2 diabetes mellitus', Diabetic Medicine, vol. 27, no. 9, hh. :977-87. Kloner, R.A., Bolli, R., Marban, E., Reinlib, L & Braunwald, E., 1998, 'Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop', Circulation, vol. 97, no. 18, hh. 1848-67. Kosiborod, M., Rathore, S.S., Inzucchi, S.E., Masoudi, F.A., Wang, Y., Havranek, E.P et al., 2005, 'Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation, vol. 111, no. 23, hh. 3078-86. Koyama, S., Sato, E., Haniuda, M., Numanami, H., Nagai, S & Izumi, T., 2002, 'Decreased level of vascular endothelial growth factor in broncoalveolar lavage fluid of normal smokers and patients with pulmory disease', American Journal of Respiratory and Critical Care Medicine, vol. 166, hh. 382-5. Kulik, G,. Klippel, A & Weber, M.J., 1997, 'Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt', Molecular and Cellular Biology, vol. 17, no. 3, hh. 1595-606. Lebuffe, G., Schumacker, P.T., Shao, Z.H., Anderson, T., Iwase, H & Vanden Hoek, T.L., 2003, 'ROS and NO trigger early preconditioning relationship to mitochondial K-ATP channels'. American Journal of Physiology, vol. 84, no. 1, hh. 299-308. Lee, S.H., Wolf, P.L., Escudero, R., Deutsch, R., Jamieson, S.W & Thistlethwaite, P.A., 2000, 'Early expression of angiogenesis factors in acute myocardial ischemia and infarction', The New England Journal of Medicine, vol. 342, no. 9, hh. 626-3. Li, D., Zhao, L., Liu, M., Du, X., Ding, W., Zhang, J et al., 1999, 'Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarctio', American Heart Journal, vol. 137, no. 6, hh. 1145-52. Li, H., Telemaque, S., Miller, R.E et al., 2005, 'High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-12 and Bcl-xl', Diabetes, vol. 54, no. 2, hh. 540-5. Libby, P., Theroux, P., 2005, 'Pathophysiology of Coronary Artery Disease', Circulation, vol. 111, no. 25, hh. 3481-8. Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I et al., 1998, 'Advanced glycation end products increase retinal vascular endothelial growth factor expression', The Journal of Clinical Investigation, vol. 101, no. 6, hh. 1219–24. Malmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma A., Dickstein, K et al., 2005, 'Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity', European Heart Journal, vol. 26 no. 7, hh. 650-61. Mansor, L.S., Mehta, K., Aksentijevic, D., Carr, C.A., Lund, T., Cole, M.A et al., 2016, 'Increased oxidative metabolisme following hypoxia in type 2 diabetec hearth, despite normal hypoxia signaling and metabolic adaptation', The Journal of Physiology, vol. 594, no. 2, hh. 307-20. Marfella, R., D’Amico, M., Di Filippo, C., Piegari, E., Nappo, F., Esposito, K et al., 2002, 'Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1', Diabetologia, vol. 45, no. 8, hh. 1172-81. Marfella, R., Esposito, K., Nappo, F., Siniscalchi, M., Sasso, F.C., Portoghese, M et al., 2004, 'Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes', Diabetes, vol. 53, no. 9, hh. 2383-91. McCormack, S & Grant, S.F.A., 2013, 'Genetics of Obesity and Type 2 Diabetes in African Americans', Journal of Obesity, vol. 2013, hh. 1-12. Meier, J.J., Deifuss, S., Klamann, A., Launhardt, V., Schmiegel, W.H & Nauck, M.A., 2005, 'Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)'. Diabetes Care, vol. 28, no. 10, hh. 2551-3. Meneghini, L., Koenen, C., Weng, W & Selam, J.L., 2007, 'The Usage of Simplified self Titration dosing guideline for insulin detemir in patient with type 2 diabetes result of the randomized, controlled predictive 303 study', Diabetes, Obesity and Metabolism, vol. 9, no. 6, hh. 902-13. Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P et al., 2006, 'Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes', Journal of the American Medical Association, vol. 295, no. 14, hh. 1681-7. Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R et al., 2013, 'ESC guidelines on the management of stable coronary artery disease'. European Heart Journal Advance, vol. 34, no. 38, hh. 2949-3003. Nakagawa, K et et al., 2000, 'Angiogenesis and its regulation: roles of vascular endothelial cell growth factor', Seminars in Thrombosis and Hemostasis, vol. 26, hh. 61-6. Oakes, N.D., Thalen, P., Aasum, E., Edgley, A., Larsen, T., Furler, S.M dkk., 2006, 'Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes', American Journal of Physiology-Endocrinology and Metabolism, vol. 290, no. 5, hh. E870-81. Oltmanns, K.M., Gehring, H., Rudolf, S., Schultes, B., Hackenberg, C., Schweiger, U et al., 2006, 'Acute hypoxia decreases plasma VEGF concentration in healthy humans', American Journal of Physiology-Endocrinology and Metabolism, vol. 290 (3): E434–9. Opie, L.H., 2003, 'Preconditioning and metabolic anti-ischaemi agents', European Heart Journal, vol. 24, no. 20, hh. 1854-6. O'Rourke, B., 2000, 'Myocardial K-ATP channel in preconditioning', Circulation research, vol. 87, no. 10, hh. 845-5. Park, C.W., Kim, H.W., Lim, J.H., Yoo, K.D., Chung, S., Shin, S.J et al., 2009, 'Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice. Diabetes, vol. 58, no. 11, 2666-7. Peterson, L.R., Herrero, P., Schechtman, K.B., Racette, S.B., Waggoner, A.D., Kisrieva-Ware, Z et al., 2004, 'Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women', Circulation, vol. 109, no. 18, hh. 2191-6. Reichelt, M.E., Shanu, A., Willems, L., Witting, P.K., Ellis, N.A., Blackburn, M.R et al, 2009, “Endogenous adenosine selectively modulates oxidant stress via the A1 receptor in ischemic hearts,” Antioxidants and Redox Signaling, vol. 11, no. 11, hh. 2641–50. Resnick, H.E., Redline, S., Shahar, E., Gilpin, A., Newman, A., Walter, R et al., 2003, 'Diabetes and Sleep Disturbances: Findings from the Sleep Heart Health Study', Diabetes Care, vol. 26, no. 3, hh 702–9. Ryu, J. K., 2008, Therapeutic angiogenesis: The pros and cons and the future', Korean Circulation Journal¸ vol. 38, hh. 73-9. Ryuichi Aikawa, Masao Nawano, Yaping Gu, Hideki Katagiri, Tomoichiro ,Asano, Weidong, Zhu, Ryozo Nagai and Issei Komuro (2000). Insulin Prevents Cardiomyocytes From Oxidative Stress−Induced Apoptosis Through Activation of PI3 Kinase/ Akt. Circulation;102:2873-2879 Rytter, L., Troelsen, S & Beck-Nielsen, H., 1985, 'Prevalence and mortality of acute myocardial infarction in patients with diabetes' Diabetes Care, vol. 8, no. 3, hh. 230-4. Santos, S et al., 2003, 'Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease', American Journal of Respiratory and Critical Care Medicine, vol. 167, hh. 1250-6. Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M & Voipio-Pulkki, L.M., 1997, 'Apoptosis in human acute myocardial infarction', Circulation, vol. 95, no. 2, hh. 320-3. Satoh, N., Shimatsu, A., Himeno, A., Sasaki, Y., Yamakage, H., Yamada, K et al., 2010, 'Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone', Diabetes Care, vol. 3, no. 1, hh. e7. Scognamiglio, R., Avogaro, A., Vigili de Kreutzenberg, S., Negut, C., Palisi, M., Bagolin, E dkk., 2002, 'Effects of treatment with sulfonylurea Drugs or insulin on ischemia, induced myocardial dysfunction in type 2 diabetes', vol. 51, no. 3, hh. 808-12. Semenza, G.L., Roth, P.H., Fang, H.M & Wang, G.L., 1994, 'Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1'. The Journal of Biological Chemistry, vol. 269, no. 38, hh. 23757-63. Semenza, G.L., 2009, 'Regulation of oxygen homeostasis by hypoxia-inducible factor 1', Physiology (Bethesda), vol. 24, hh. 97-106. Sergiu, Zheng, 2020. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia, 64:709–716 Shah, A.D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, CP et al., 2015, 'Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people', The Lancet Diabetes & Endocrinology, vol. 3, no. 2, hh. 105-13. Shaw, Hypoxia-regulated gene network in drug resistance and cancer progressio Hypoxia-regulated gene network in drug resistance and cancer progressio Shaw Chieh S, Wan L. 2014. Hypoxia regulated gen network in drug resistance in cancer progression, Exp Biol Med. doi:10.1177. Shoba.Rhao, Philip, Tamara.,2009. Impaired Glucose Tolerance and Impaired Fasting Glucose. Am Fam Physician 2004;69:1961-8,1971-2. Silva, M.M., Sartori, A., Belisle, E & Kowaltowski, A.J., 2003, 'Ischemic preconditioning inhibits mitochondrial respiration, increase H2O2 release and enhances K+ transport', American Journal of Physiology-Heart and Circulatory Physiology, vol. 285, no. 1, hh. H154-62. Singh, J.P., Larson, M.G., O’Donnell, C.J., Wilson, P.F., Tsuji, H., Lloyd-Jones, D.M et al., 2000, 'Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)', American Journal of Cardiology, vol. 86, no. 3, hh. 309-12. Spangenberg, E., Remes, C., Mikkelsen, L.F & Cvek, K., 2011, 'Effects of Alternative Housing Systems on Physical and Social Activity in Male Sprague Dawley and Spontaneously Hypertensive Rats', Scandinavian Journal of Laboratory Animal Science, vol. 38, no. 1, hh.47-66. Spycher, S.E et al., 1997, 'Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells', FASEB Journal, vol. 11, no 2, hh. 181-8. Srinivasan, S., Stevens, M & Wiley, J.W., 2000, 'Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction', Diabetes, vol. 49, no. 11, hh. 1932-8. Stranders, I., Diamant, M., van Gelder, R.E., Spruijt, H.J., Twisk, J.W., Heine, R.J et al., 2004, 'Admission blood glucose level as risk indicator of death after myocardialinfarction in patients with and without diabetes mellitus', Archives of internal medicine American Medical Association, vol. 164, no. 9, hh. 982-8. Sung, H.K., Doh, K.O., Son, J.E., Park, J.G., Bae, Y., Choi, S dkk., 2013, 'Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis', Cell Metabolism, vol. 17, no. 1, hh. 61-72. Swynghedauw, B., 1999, 'Molecular mechanisms of myocardial remodeling'. Physiological Reviews, vol. 79, no. 1, hh. 215-62. Taegtmeyer, H., Golfman, L., Sharma, S., Razeghi, P & van Arsdall, M., 2004, 'Linking gene expression to function: metabolic flexibility in the normal and diseased heart', Annals of the New York Academy of Sciences, vol. 1015, hh. 202-13. Treins C, Peraldi S, Murdaca J, Semenza, Obberghen E., 2002, Insulin stimulates Hypoxia Inducible factor 1 through a phosphatidylinositol 3-kinase/ target of rapamycin-dependent signaling pathway. Journal of Biological Chemistry Vol.277 272795-27981.27975-27981 Wahab, N.N., Cowden, E.A., Pearce, N.J., Gardner, M.J., Merry, H & Cox, J.L., 2002, 'Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?', Journal of the American College of Cardiology, vol. 40, no. 10, hh. 1748-54. Wang, Y., Zhu, Y.D., Gui, Q., Wang, X.D & Zhu, Y.X., 2014, 'Glucagon-induced angiogenesis and tumor growth through the HIF-1-VEGF-dependent pathway in hyperglycemic nude mice', Genetics and Molecular Research, vol. 13, no. 3, hh. 7173-83. White, M.F & Kahn, C.R., 1994, 'The insulin signaling system', The Journal of Biological Chemistry, vol. 269, no.1, hh. 1-4. Willam, C., Maxwell, P.H., Nichols, L., Lygate, C., Tian, Y.M., Bernhardt, W et al., 2006, 'HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation', Journal of Molecular and Cellular Cardiology, vol. 41, no. 1, hh. 68-77. Wolf, B.B & Green, D.R., 1999, 'Suicidal tendencies: apoptotic cell death by caspase family proteinases', Journal of Biological Chemistry, vol. 274, no. 29, hh. 20049-52. Xue, W., Liu, Y., Zhao, J., Cai, L., Li, X & Feng, W., 2012, 'Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart' American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 12, hh. H2528-35. Yang, Z., Laubach, V.E., French, B.A & Kron, I.L., 2009, 'Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion', Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 3, hh. 723–9. Yang, Z., Tian, Y., Liu,Y., Hennessy, S., Kron, I.L & French, B.A., 2013, 'Acute Hyperglycemia Abolishes Ischemic Preconditioning by Inhibiting Akt Phosphorylation: Normalizing Blood Glucose before Ischemia Restores Ischemic Preconditioning', Oxidative Medicine and Cellular Longevity, vol. 2013, hh. 1-8. Yaoita, H., Ogawa, K., Maehara, K & Maruyama, Y., 1998, 'Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor', Circulation, vol. 97, no. 3, hh. 276-81. Yao, Q., Shin, M.K., Jun, J.C., Hernandez, K.L., Aggarwal, N.R., Mock, J.R et al., 2013, 'Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues', The Journal of Lipid Research, vol. 54, no. 4, hh. 1058-65. Young-Woong Kim, Tatiana V. Byzova .2013. Oxidative stress in angiogenesis and vascular disease. Blood First Ed, DOI 10.1182/blood- 2013-09-512749. Yu H, Che X, Zeng M Insulin protects apoptotic cardiomyocytes from hypoxia/reoxygenation injury through the sphingosine kinase/sphingosine 1-phosphate axis. PLoS ONE 8(12): e80644. doi:10.1371/ Yuan, G., Nanduri, J., Bhasker, C.R., Semenza, G.L & Prabhakar, N.R., 2005, 'Calmodulin kinase dependent activation of hypoxia inducible factor-1 transcriptional activity in cell subjected of intermitten hypoxia', Journal of Biological Chemistry, vol. 280, no. 6, hh. 4321-8. Yuan, G., Nandhuri, J., Khan, S., Semenza, G.L & Prabhakar, N.R., 2008, 'Induction of HIF-1 expression by intermitten hypoxia; involvement NADPH oxidase Ca signaling prolylhydroxylase', Journal of Cellular Physiology, vol. 217, no. 3, hh. 674-85. Zhou Q, Fu B, Hu X, Reactive oxygen spesies regulate insulin –induced VEGF and HIF-1 alpha expression through the activation of p70S6K1 in human prostate cancer cells, Carcinogenesis 28(1):28-37
local.eprints.dirdisk0/00/46/33/91
local.eprints.divisionS3
local.eprints.id463391
local.eprints.typethesis/doctoral
local.eprints.urihttp://scholar.unand.ac.id/463391/
local.fakultasPascasarjana (S3)
local.identifier.nim2030312027
local.thesis.levelDisertasi

Files

Collections